Literature DB >> 17382907

Transgenic expression of osteoactivin in the liver attenuates hepatic fibrosis in rats.

Hiroo Abe1, Hirofumi Uto, Yoichiro Takami, Yuka Takahama, Satoru Hasuike, Mayumi Kodama, Kenji Nagata, Akihiro Moriuchi, Masatsugu Numata, Akio Ido, Hirohito Tsubouchi.   

Abstract

The role of osteoactivin (OA) in liver fibrogenesis remains unclear. After feeding wild-type (WT) and OA transgenic (OA-Tg) rats a choline-deficient, L-amino acid-defined (CDAA) diet for 12 weeks, we evaluated liver fibrosis. Hepatic fibrosis and expression of alpha-smooth muscle actin protein in OA-Tg rats were reduced in comparison to WT rats. Our examination of the expression of 31,100 genes by microarray analysis identified 177 and 256 genes that were upregulated and downregulated, respectively, by at least twofold in OA-Tg rat livers in comparison to WT rat livers. Of these genes, we confirmed a significant downregulation in the expression levels of tissue inhibitor of metalloproteinase-1 and -2, type I collagen, and platelet-derived growth factor receptor-alpha and -beta in the livers of OA-Tg rats. These results indicate that transgenic OA expression attenuates the development of hepatic fibrosis in association with the suppression of specific genes involved in its pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17382907     DOI: 10.1016/j.bbrc.2007.03.035

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  16 in total

Review 1.  Glycoprotein nonmetastatic melanoma protein B: A key mediator and an emerging therapeutic target in autoimmune diseases.

Authors:  Pei-Suen Tsou; Amr H Sawalha
Journal:  FASEB J       Date:  2020-05-23       Impact factor: 5.191

2.  Comparison of bone morphogenetic protein-2 and osteoactivin for mesenchymal cell differentiation: effects of bolus and continuous administration.

Authors:  Oneida A Arosarena; Fabiola E Del Carpio-Cano; Raul A Dela Cadena; Mario C Rico; Emeka Nwodim; Fayez F Safadi
Journal:  J Cell Physiol       Date:  2011-11       Impact factor: 6.384

Review 3.  GPNMB: a potent inducer of immunosuppression in cancer.

Authors:  Anna-Maria Lazaratos; Matthew G Annis; Peter M Siegel
Journal:  Oncogene       Date:  2022-09-01       Impact factor: 8.756

4.  Bioinformatics multivariate analysis determined a set of phase-specific biomarker candidates in a novel mouse model for viral myocarditis.

Authors:  Seiichi Omura; Eiichiro Kawai; Fumitaka Sato; Nicholas E Martinez; Ganta V Chaitanya; Phoebe A Rollyson; Urska Cvek; Marjan Trutschl; J Steven Alexander; Ikuo Tsunoda
Journal:  Circ Cardiovasc Genet       Date:  2014-07-16

5.  The soluble glycoprotein NMB (GPNMB) produced by macrophages induces cancer stemness and metastasis via CD44 and IL-33.

Authors:  M Liguori; E Digifico; A Vacchini; R Avigni; F S Colombo; E M Borroni; F M Farina; S Milanesi; A Castagna; L Mannarino; I Craparotta; S Marchini; E Erba; N Panini; M Tamborini; V Rimoldi; P Allavena; C Belgiovine
Journal:  Cell Mol Immunol       Date:  2020-07-29       Impact factor: 11.530

6.  Targeted overexpression of osteoactivin in cells of osteoclastic lineage promotes osteoclastic resorption and bone loss in mice.

Authors:  Matilda H-C Sheng; Jon E Wergedal; Subburaman Mohan; Mehran Amoui; David J Baylink; K-H William Lau
Journal:  PLoS One       Date:  2012-04-20       Impact factor: 3.240

7.  Comprehensive characterization of mesenchymal stem cells from human placenta and fetal membrane and their response to osteoactivin stimulation.

Authors:  C M Raynaud; M Maleki; R Lis; B Ahmed; I Al-Azwani; J Malek; F F Safadi; A Rafii
Journal:  Stem Cells Int       Date:  2012-06-04       Impact factor: 5.443

8.  Glycoprotein non-metastatic melanoma B expression after hepatic ischemia reperfusion and the effect of silibinin.

Authors:  Adamantios Michalinos; Alexandra K Tsaroucha; Maria Lambropoulou; Dimitrios Schizas; Georgia Valsami; Nikolaos Kostomitsopoulos; Michael S Pitiakoudis; Constantinos E Simopoulos
Journal:  Transl Gastroenterol Hepatol       Date:  2020-01-05

9.  Functional Domains and Evolutionary History of the PMEL and GPNMB Family Proteins.

Authors:  Paul W Chrystal; Tim Footz; Elizabeth D Hodges; Justin A Jensen; Michael A Walter; W Ted Allison
Journal:  Molecules       Date:  2021-06-09       Impact factor: 4.411

10.  Glycoprotein Nonmetastatic Melanoma B (Gpnmb)-Positive Macrophages Contribute to the Balance between Fibrosis and Fibrolysis during the Repair of Acute Liver Injury in Mice.

Authors:  Kotaro Kumagai; Kazuaki Tabu; Fumisato Sasaki; Yoichiro Takami; Yuko Morinaga; Seiichi Mawatari; Shinichi Hashimoto; Shiroh Tanoue; Shuji Kanmura; Tsutomu Tamai; Akihiro Moriuchi; Hirofumi Uto; Hirohito Tsubouchi; Akio Ido
Journal:  PLoS One       Date:  2015-11-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.